Pneumocystis jirovecii Pneumonia in Solid-Organ Transplant Recipients: A National Center Experience.
CONCLUSIONS: The overall prevalence of P. jirovecii pneumonia in solid-organ transplant recipients was similar to other single-center reports. Prophylaxis prevented early posttransplant P. jirovecii pneumonia. However, P. jirovecii pneumonia may develop at any posttransplant stage, and viral infections other than cytomegalovirus should also be considered as a predictor.
PMID: 33272151 [PubMed - as supplied by publisher]
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - Category: Transplant Surgery Authors: Ozgen Alpaydin A, Avkan Oguz V, Cakmakci S, Erguden C, Egeli T, Yildiz S, Derici S, Ozkoc S Tags: Exp Clin Transplant Source Type: research
More News: Bronchoscopy | Cytomegalovirus | Intensive Care | Kidney Transplant | Kidney Transplantation | Liver | Liver Transplant | Middle East Health | Pancreas | Pneumonia | Study | Transplant Surgery | Transplants | Urology & Nephrology